• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

提高自失活γ-逆转录病毒和慢病毒载体的转录终止效率。

Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors.

作者信息

Schambach Axel, Galla Melanie, Maetzig Tobias, Loew Rainer, Baum Christopher

机构信息

1Department of Experimental Hematology, Hannover Medical School, Hannover, Germany.

出版信息

Mol Ther. 2007 Jun;15(6):1167-73. doi: 10.1038/sj.mt.6300152. Epub 2007 Apr 3.

DOI:10.1038/sj.mt.6300152
PMID:17406345
Abstract

Adverse events relating to insertional mutagenesis have reinforced the interest in self-inactivating (SIN) gamma-retroviral and lentiviral vectors without enhancer-promoter sequences in the U3 region of the long terminal repeats. However, SIN vectors suffer from leaky transcriptional termination, increasing the probability of read-through into cellular genes. To improve 3' end processing, we incorporated seven upstream polyadenylation enhancer elements (or upstream sequence elements, USEs) derived from viral or cellular genes into the 3' U3 region of gamma-retroviral and lentiviral SIN vectors. A 100-base-pair sequence representing a recombinant direct repeat of the USE derived from simian virus 40 (2xSV USE) gave the best results, improving both titer and gene expression. In both gamma-retroviral and lentiviral SIN vectors, the 2xSV USE partially substituted for effects provided by the much larger post-transcriptional regulatory element derived from woodchuck hepatitis virus (wPRE). By northern blot and reporter assays, we found that the 2xSV USE greatly improved proper messenger RNA (mRNA) processing at the retroviral termination signal. Importantly, the 2xSV USE was superior to the wPRE in suppressing transcriptional read-through, improving not only vector efficiency but potentially also biosafety.

摘要

与插入诱变相关的不良事件,增强了人们对长末端重复序列U3区域不含增强子-启动子序列的自失活(SIN)γ逆转录病毒载体和慢病毒载体的兴趣。然而,SIN载体存在转录终止渗漏问题,增加了通读进入细胞基因的可能性。为了改善3'端加工,我们将七个源自病毒或细胞基因的上游聚腺苷酸化增强元件(或上游序列元件,USEs)整合到γ逆转录病毒和慢病毒SIN载体的3' U3区域。一个代表源自猿猴病毒40的USE重组直接重复序列的100个碱基对序列(2xSV USE)产生了最佳结果,提高了滴度和基因表达。在γ逆转录病毒和慢病毒SIN载体中,2xSV USE部分替代了源自土拨鼠肝炎病毒(wPRE)的大得多的转录后调控元件所提供的效应。通过Northern印迹和报告基因检测,我们发现2xSV USE极大地改善了逆转录病毒终止信号处信使RNA(mRNA)的正确加工。重要的是,2xSV USE在抑制转录通读方面优于wPRE,不仅提高了载体效率,还可能提高了生物安全性。

相似文献

1
Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors.提高自失活γ-逆转录病毒和慢病毒载体的转录终止效率。
Mol Ther. 2007 Jun;15(6):1167-73. doi: 10.1038/sj.mt.6300152. Epub 2007 Apr 3.
2
The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors.土拨鼠肝炎病毒转录后调控元件可减少逆转录病毒载体的通读转录。
Gene Ther. 2007 Sep;14(17):1298-304. doi: 10.1038/sj.gt.3302979. Epub 2007 Jun 28.
3
Self-inactivating lentiviral vectors with U3 and U5 modifications.具有U3和U5修饰的自失活慢病毒载体。
Virology. 1999 Aug 15;261(1):120-32. doi: 10.1006/viro.1999.9850.
4
Overlapping enhancer/promoter and transcriptional termination signals in the lentiviral long terminal repeat.慢病毒长末端重复序列中的重叠增强子/启动子和转录终止信号
Retrovirology. 2007 Jan 22;4:4. doi: 10.1186/1742-4690-4-4.
5
B-cell-specific transgene expression using a self-inactivating retroviral vector with human CD19 promoter and viral post-transcriptional regulatory element.使用具有人CD19启动子和病毒转录后调控元件的自失活逆转录病毒载体进行B细胞特异性转基因表达。
Gene Ther. 2004 Jun;11(12):992-1000. doi: 10.1038/sj.gt.3302255.
6
Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.γ逆转录病毒载体和慢病毒自我失活(SIN)载体在造血细胞中表达O6-甲基鸟嘌呤-DNA甲基转移酶的效力相同。
Mol Ther. 2006 Feb;13(2):391-400. doi: 10.1016/j.ymthe.2005.08.012. Epub 2005 Oct 12.
7
Self-inactivating retroviral vectors with improved RNA processing.具有改进RNA加工能力的自失活逆转录病毒载体
Gene Ther. 2004 Nov;11(21):1568-78. doi: 10.1038/sj.gt.3302309.
8
Risk assessment in skin gene therapy: viral-cellular fusion transcripts generated by proviral transcriptional read-through in keratinocytes transduced with self-inactivating lentiviral vectors.皮肤基因治疗中的风险评估:自失活慢病毒载体转导的角质细胞中通过前病毒转录通读产生的病毒-细胞融合转录本。
Gene Ther. 2011 Jul;18(7):674-81. doi: 10.1038/gt.2011.12. Epub 2011 Mar 3.
9
Production of lentiviral vectors for transducing cells from the central nervous system.用于转导中枢神经系统细胞的慢病毒载体的生产。
J Vis Exp. 2012 May 24(63):e4031. doi: 10.3791/4031.
10
Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a γ-retroviral LTR vector.比较用慢病毒 SIN 或 γ 逆转录病毒 LTR 载体标记的造血干细胞移植后重建动力学的克隆分析。
Exp Hematol. 2013 Jan;41(1):28-38.e3. doi: 10.1016/j.exphem.2012.09.003. Epub 2012 Sep 16.

引用本文的文献

1
Transcription Factor Binding Site in Promoter Determines the Pattern of Plasmid-Based Transgene Expression In Vivo.启动子中的转录因子结合位点决定了基于质粒的转基因在体内的表达模式。
Pharmaceutics. 2024 Apr 15;16(4):544. doi: 10.3390/pharmaceutics16040544.
2
Application of the iPLUS non-coding sequence in improving biopharmaceuticals production.iPLUS非编码序列在提高生物制药产量中的应用。
Front Bioeng Biotechnol. 2024 Feb 6;12:1355957. doi: 10.3389/fbioe.2024.1355957. eCollection 2024.
3
Neurotrophic factor-based pharmacological approaches in neurological disorders.
基于神经营养因子的神经系统疾病药理学方法。
Neural Regen Res. 2023 Jun;18(6):1220-1228. doi: 10.4103/1673-5374.358619.
4
CAR-T cell potency: from structural elements to vector backbone components.嵌合抗原受体T细胞效力:从结构元件到载体骨架组件
Biomark Res. 2022 Sep 19;10(1):70. doi: 10.1186/s40364-022-00417-w.
5
E2F4-Based Gene Therapy Mitigates the Phenotype of the Alzheimer's Disease Mouse Model 5xFAD.基于 E2F4 的基因治疗减轻阿尔茨海默病小鼠模型 5xFAD 的表型。
Neurotherapeutics. 2021 Oct;18(4):2484-2503. doi: 10.1007/s13311-021-01151-1. Epub 2021 Nov 11.
6
Potency Testing of Subretinal rAAV5.hCNGB1 Gene Therapy in the Knockout Mouse Model of Retinitis Pigmentosa.视网膜下 rAAV5.hCNGB1 基因治疗在色素性视网膜炎基因敲除小鼠模型中的效价测试。
Hum Gene Ther. 2021 Oct;32(19-20):1158-1170. doi: 10.1089/hum.2021.121. Epub 2021 Sep 20.
7
Re-structuring lentiviral vectors to express genomic RNA via cap-dependent translation.通过帽依赖性翻译重组慢病毒载体以表达基因组RNA。
Mol Ther Methods Clin Dev. 2020 Dec 15;20:357-365. doi: 10.1016/j.omtm.2020.12.005. eCollection 2021 Mar 12.
8
Gene Therapy Applications of Non-Human Lentiviral Vectors.非人类慢病毒载体的基因治疗应用。
Viruses. 2020 Sep 29;12(10):1106. doi: 10.3390/v12101106.
9
Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side.基于自体造血干细胞的免疫缺陷基因治疗的临床前开发:从小鼠笼到床边的历程
Pharmaceutics. 2020 Jun 13;12(6):549. doi: 10.3390/pharmaceutics12060549.
10
Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays.眼基因治疗临床试验和转基因表达及生物活性测定中的重组腺相关病毒载体(rAAV)-载体元件。
Int J Mol Sci. 2020 Jun 12;21(12):4197. doi: 10.3390/ijms21124197.